Towards the end of eliminating suffering and death from cancer, the National Cancer Institute is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, image and treat cancer.

NCI programs conducted over the past five years have supported research on novel nanodevices that may detect and pinpoint the location of cancer at its earliest stages, deliver anticancer drugs specifically to malignant cells, and determine in real-time if these drugs are effective in killing malignant cells.

We envision that nanotechnology will change the very foundations of cancer diagnosis, treatment and prevention.

The NCI Alliance for Nanotechnology in Cancer is a national initiative that will enable us to join together all the communities in the public and private sector that provide discovery, innovation and development expertise in nanotechnology applied to cancer. The Alliance is built on a strong foundation of science and scientific accomplishment. Its implementation will be guided by the Cancer Nanotechnology Plan.

We invite researchers from all disciplines to participate in this new and promising initiative against cancer.